All Stories

  1. Pharmacogenomic Diversity among Arab Populations: A Systematic Review

    Article • iScience, February 2026, Elsevier

    Zeina Almahayri

  2. Evaluation of the functional impact of rare CYP2C19 missense variants identified in understudied Populations: An Integrated in silico and in vitro analysis

    Article • Biochemical Pharmacology, December 2025, Elsevier

    Zeina Almahayri

  3. Ezetimibe and the risk of new-onset type 2 diabetes: a systematic review and meta-analysis

    Article • Annals of Medicine, November 2025, Taylor & Francis

    Zeina Almahayri

  4. Pharmacogenomic biomarkers of ACE inhibitor–induced cough in a multi-ethnic UAE cohort

    Article • Frontiers in Pharmacology, September 2025, Frontiers

    Zeina Almahayri

  5. A multi-centre observational cohort study on pharmacogenomic predictors of rosuvastatin discontinuation in a multiethnic population

    Article • Frontiers in Pharmacology, August 2025, Frontiers

    Zeina Almahayri

  6. Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates

    Article • Clinical and Translational Science, August 2025, Wiley

    Maram Abbas, Zeina Almahayri

  7. Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE’s multiethnic population

    Article • Human Genomics, April 2025, Springer Science + Business Media

    Zeina Almahayri

  8. Revisiting Chromosomal Translocations: Insights From Healthy Individuals and Lymphoma

    Article • The Journal of Applied Laboratory Medicine, March 2025, Oxford University Press (OUP)

    Zeina Almahayri

  9. Challenges in improving genomic literacy, knowledge, and awareness

    Article • January 2025, Elsevier

    Zeina Almahayri

  10. Contributors

    Article • January 2025, Elsevier

    Zeina Almahayri

  11. Comparative Analysis of Atorvastatin and Rosuvastatin Side Events and Risk Factors in the UAE Multiethnic Population: Focus on Pharmacogenomic Variants

    Article • November 2024, Wiley

    Zeina Almahayri

  12. Meta-analysis of genomic variants in power and endurance sports to decode the impact of genomics on athletic performance and success

    Article • Human Genomics, May 2024, Springer Science + Business Media

    Zeina Almahayri

  13. Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population

    Article • Current Vascular Pharmacology, May 2024, Bentham Science Publishers

    Zeina Almahayri, Mais Alqasrawi, Bassam Ali

  14. Safety Pharmacology in the Era of Precision Medicine

    Article • January 2024, Springer Science + Business Media

    Zeina Almahayri

  15. Safety Pharmacology in the Era of Precision Medicine

    Article • January 2024, Springer Science + Business Media

    Zeina Almahayri

  16. Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations

    Article • Frontiers in Pharmacology, December 2023, Frontiers

    Zeina Almahayri

  17. The Utility of CYP2D6 and CYP2C19 Variants to Guide Pharmacological Treatment in Complex Unipolar Major Depression: A Pilot Longitudinal Study

    Article • Psychiatric Quarterly, July 2023, Springer Science + Business Media

    Zeina Almahayri

  18. Pharmacogenomics at the post-pandemic: If not now, then when?

    Article • Frontiers in Pharmacology, September 2022, Frontiers

    Zeina Almahayri

  19. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates

    Article • Human Genomics, September 2022, Springer Science + Business Media

    Zeina Almahayri

  20. Mendelian randomization in pharmacogenomics: The unforeseen potentials

    Article • Biomedicine & Pharmacotherapy, June 2022, Elsevier

    Zeina Almahayri

  21. Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?

    Article • Frontiers in Oncology, October 2021, Frontiers

    Zeina Almahayri

  22. Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide

    Article • Human Genetics, October 2021, Springer Science + Business Media

    Zeina Almahayri

  23. Current opinion on the pharmacogenomics of paclitaxel-induced toxicity

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2021, Taylor & Francis

    Zeina Almahayri

  24. Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm)

    Article • Human Genome Variation, February 2021, Springer Science + Business Media

    Zeina Almahayri

  25. Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations

    Article • Scientific Reports, December 2020, Springer Science + Business Media

    Zeina Almahayri

  26. Association of variants inPTPN22,CTLA‐4,IL2‐RA, andINSgenes with type 1 diabetes in Emiratis

    Article • Annals of Human Genetics, September 2020, Wiley

    Zeina Almahayri

  27. Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy

    Article • Frontiers in Pharmacology, April 2020, Frontiers

    Zeina Almahayri

  28. VKORC1 variants as significant predictors of warfarin dose in Emiratis

    Article • Pharmacogenomics and Personalized Medicine, April 2019, Dove Medical Press

    George Patrinos, Zeina Almahayri, Bassam Ali

  29. Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations

    Article • Pharmacogenomics, May 2017, Future Medicine

    Zeina Almahayri

  30. Genotype–phenotype spectrum of PYCR1-related autosomal recessive cutis laxa

    Article • Molecular Genetics and Metabolism, November 2013, Elsevier

    Zeina Almahayri

  31. High prevalence of genetic abnormalities in Middle Eastern patients with idiopathic non-obstructive azoospermia

    Article • Journal of Assisted Reproduction and Genetics, April 2013, Springer Science + Business Media

    Prof Marwan Alhalabi, Zeina Almahayri

  32. GJB2 gene mutations in Syrians with sensorineural hearing loss

    Article • Middle East Journal of Medical Genetics, July 2012, Egypts Presidential Specialized Council for Education and Scientific Research

    Zeina Almahayri

  33. A review of 1125 cases referred for cytogenetic analysis in Syria

    Article • Middle East Journal of Medical Genetics, January 2012, Egypts Presidential Specialized Council for Education and Scientific Research

    Zeina Almahayri